Product NDC: | 0591-3592 |
Proprietary Name: | DRONABINOL |
Non Proprietary Name: | DRONABINOL |
Active Ingredient(s): | 5 mg/1 & nbsp; DRONABINOL |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-3592 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018651 |
Marketing Category: | NDA |
Start Marketing Date: | 20050607 |
Package NDC: | 0591-3592-60 |
Package Description: | 60 CAPSULE in 1 BOTTLE, PLASTIC (0591-3592-60) |
NDC Code | 0591-3592-60 |
Proprietary Name | DRONABINOL |
Package Description | 60 CAPSULE in 1 BOTTLE, PLASTIC (0591-3592-60) |
Product NDC | 0591-3592 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DRONABINOL |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20050607 |
Marketing Category Name | NDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | DRONABINOL |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |